Skip to content

Protocol-Based Ayurvedic Treatment in Benign Prostatic Hyperplasia with Emphasis on Uttara Basti

A protocol-based clinical evaluation of Mutraghata Chikitsa (Benign Prostatic Hyperplasia) with emphasis on Uttara basti - A single arm open labelled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111356
Enrollment
30
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N400- Benign prostatic hyperplasia without lower urinary tract symptoms

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda ITRA Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The male patients of age 40 to 70 years. 2. The patients having 3 or more than 3 of above-mentioned signs and symptoms of Mutraghata (BPH) 3. The patients who are willing and Yogya (fit) for Virechana and Uttara Basti

Exclusion criteria

Exclusion criteria: 1. Patients of age below 40 years and above 70 years. 2. Patients of malignancy, congenital deformities of urogenital tract or any abdominal-pelvic pathology other than BPH. 3. Systemic diseases like chronic renal failure (CRF), Uncontrolled Hypertension (BP greater then 150/90 mmHg), diabetes mellitus (RBS greater then 140 mg/dl), 4. Patients having Haematuria (Blood in the urine), Bladder infection (UTI), kidney stone, Bladder stones. 5. Patient of k/c/o Tuberculosis, Paralysis, and Parkinsonism will be excluded. 6. Known case of cardiac diseases (H/O- MI, IHD). 7. Patient having HIV, HBsAg, HCV, VDRL positive. 8. The patients who are not willing and Ayogya (unfit) for Virechana and Uttara Basti

Design outcomes

Primary

MeasureTime frame
Improvement in the sign and symptoms of Mutraghata (Benign Prostatic Hyperplasia) and Quality of lifeTimepoint: 32 Days

Secondary

MeasureTime frame
UFR (Urine flow rate) by Uroflometry PVRU (Post voidal residual urine) Size of prostrate by TRUS USG Abdomen Pelvis International Prostate Symptom Score (IPSS) Erectile Function Score (EFS) Male Sexual Function (MSF) ScoreTimepoint: End of treatment

Countries

India

Contacts

Public ContactDr TS Dudhamal

INSTITUTE OF TEACHING AND RESEARCH IN AYURVEDA JAMNAGER

drtsdudhamal@gmail.com8849298620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026